Women With Early Stage Breast Cancer Can Skip Chemo, Study Says

Leslie Hanson
June 8, 2018

She sent two of her friends with cancer to Rosenberg's lab for the same treatment and both of them died, NBC reported.

In the USA and other developed nations, most patients are diagnosed with breast cancer at early stages and, therefore, they can benefit more from such tests.

One of the goals of the Vera Bradley Foundation Center for Breast Cancer Research will be to increase clinical trial access to women facing cancer in Indiana.

According to first author Joseph Sparano of Montefiore Medical Centre in NY, "any woman with early-stage breast cancer 75 or younger should have the test and discuss the results" with her doctor. Medical practitioners who are handling the case of Judy at the National Cancer Institute, Maryland, the USA, said, "The response that they receive from the therapy is unbelievable, as it eliminated all the cancerous cells effectively and she has now been free from the disease since her treatment". Results were discussed Sunday at an American Society of Clinical Oncology conference in Chicago and published by the New England Journal of Medicine. Few of the researchers consult the drug-makers and companies manufacturing the medicine and conducting gene test for breast cancer. The other 16% of women with low-risk are aware of the fact that they can opt out chemotherapy and can go with other treatment alternatives.

He is Kropp's doctor and is excited at not just the results, but knowing local women were part of it.

84 percent were alive without signs of cancer, so adding chemo made no difference. A genetic expression profile can determine recurrence rates.

Over the years, the Cancer Institute has used its $59.8 million in proceeds for studies trying to improve early detection and to determine which cancers are most risky and need heaviest treatment and which are less so.

'We've developed a high-throughput method to identify mutations present in a cancer that are recognized by the immune system, ' Dr. Rosenberg said.


Most breast cancer patients, almost 70% of them, fall in this category and experts overseas said they will benefit from the findings.

Study results will provide women more accurate information when weighing treatment options, and help ensure that women receive the optimal level of care instead of over-treatment. The money was used to pay for the gene test, which costs more than $4,000 per person.

Dr. Ned Sharpless, director, National Cancer Institute at the National Institutes of Health.

The study involved more than 10,000 breast cancer patients from across the country - some of whom were patients at the University of Minnesota.

"I think it's been well spent", Singer said of the stamp proceeds.

"The very mutations that cause cancer turn out to be its Achilles heel", Rosenberg told the BBC.

At Mosaic Life Care, we have been using this personalized approach for five years and the study results were a confirmation of our treatment guidelines.

Other reports by Iphone Fresh

Discuss This Article

FOLLOW OUR NEWSPAPER